Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Newstrike Brands Ltd NWKRF

"Newstrike Brands Ltd is a licensed producer and cultivator of medical cannabis based in Brantford, Ontario. The company cultivates and sells both forms including dried and fresh marihuana."

OTCPK:NWKRF - Post Discussion

Newstrike Brands Ltd > Chill pill time
View:
Post by LongTbuffet on Jan 16, 2018 12:28pm

Chill pill time

HIP got shorted. Stock will go back down to $1.00. Shares will be covered, deal will happen and stock will go back up to $3.30. No the CEO’s fault
Comment by MNK3240 on Jan 16, 2018 12:33pm
You are right until first statement. But it will not have a chance to to back up to $3.30 becz. the HIP shares will be converted to CMED after deal and you will end up with 0.83c. after merger, there will be no HIP, one morning you will find CMED shares but only 33 shares for your each 1000 shares of HIP.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities